Last Price
1.38
Today's Change
+0.02 (1.47%)
Day's Change
1.37 - 1.47
Trading Volume
101,207
Profile
SXTP
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Geoffrey Stuart Dow Dr. Geoffrey Stuart Dow
Full Time Employees: 3 3
IPO Date: 2023-07-12 2023-07-12
CIK: 0001946563 0001946563
ISIN: US83006G1040 US83006G1040
CUSIP: 83006G104 83006G104
Beta: 5.27 5.27
Last Dividend: 0.00 0.00
Dcf Diff: 1.07 1.07
Dcf: 0.31 0.31
Description
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
US Producer Prices Pick Up Slightly After Downward Revisions
3
CEO Morning Brief
4
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
